Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroendocrine Tumors × Critical Pathways × 90 days × Clear all

Sponsor

Interventions

lutetium Lu 177 dotatate 10 Magnetic Resonance Spectroscopy 6 Everolimus 6 Specimen Handling 5 pembrolizumab 4 cabozantinib 4 olaparib 3 lenvatinib 3 Nivolumab 3 lanreotide 2 gallium Ga 68 dotatate 2 avelumab 2 atezolizumab 2 X-Rays 2 Radiotherapy 2 Phantoms, Imaging 2 Octreotide 2 Lutetium-177 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Etoposide 2 Cyclophosphamide 2 Cisplatin 2 177Lu-octreotide, DOTA(0)-Tyr(3)- 2 tivozanib 1 telotristat ethyl 1 surufatinib 1 repotrectinib 1 peposertib 1 pazopanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡